Cross-border Healthcare Directive
The purpose of the Cross-Border Directive (Directive 2011/24/EU on patients’ rights in cross-border healthcare) is to identify patients' rights in cross-border healthcare, facilitate cooperation between patients and healthcare professionals. The Directive applies to members of the European Union, the European Economic Area (Iceland, Norway, Liechtenstein) and Switzerland.
The introduction of a Cross-border Directive will enable patients:
- To contact national contact points (in Latvia – the National Health Service), who will provide information on healthcare in the certain country and on how to receive healthcare in other EU countries, Iceland, Norway, Liechtenstein and Switzerland;
- To receive reimbursement of expenses for planned healthcare received in another country;
- To use one country's issued prescription for medicine/medical device to receive this medicine/device in another country;
- To receive reimbursement for damage caused to health by a medical institution - in Latvia, for the purpose of its implementation, the Medicines Risk Fund was established by the National Health Service.
Members of World Medical Export Association: